{
    "SPADE_UN_25511": {
        "Sequence Information": {
            "Peptide Name": "Elisidepsin, PM02734",
            "Sequence": "VTVVPXXXXVFXV",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anticancer"
            ],
            "Binding Target": "1. Lysosomal membrane\n2. Mitochondrial membrane",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models.",
                    "Pubmed ID": "19346126",
                    "Reference": "Eur J Cancer. 2009;45:1855-1864",
                    "Author": "Ling YH, Aracil M, Jimeno JM, Perez-Soler R, Zou Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19346126"
                },
                {
                    "Title": "Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound",
                    "Pubmed ID": "23519149",
                    "Reference": "Mar Drugs. 2013;11:944-959",
                    "Author": "Serova M, Gramont A, Bieche I, Riveiro ME, Galmarini CM, Aracil M, Jimeno JM, Faivre S, Raymond E",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23519149"
                }
            ],
            "SPADE ID": "SPADE_UN_25511",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02196",
                    "Similarity": 1.0,
                    "Sequence": "ADDRNPLEQCFRETDYEEFLEIARNNLKATSNPKHVVIVGAGMAGLSAAYVLSGGGHQVTV"
                },
                {
                    "SPADE_ID": "SPADE_UN_06687",
                    "Similarity": 1.0,
                    "Sequence": "ILFLSIFLCIIVSNSSFSKTFDRACKTDKDCPKLRGVNVRCRKDQCVTV"
                },
                {
                    "SPADE_ID": "SPADE_UN_07143",
                    "Similarity": 1.0,
                    "Sequence": "KTFDRACKTDKDCPKLRGVNVRCRKDQCVTV"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Human lung adenocarcinoma NCI-H322(IC50=0.30±0.15µM),Human lung carcinoma A549(IC50=0.58±0.25µM),Human lung adenocarcinoma NCI-H3255(IC50=1.00±0.25µM),Human lung carcinoma NCI-H661(IC50=1.50±0.85µM),Human lung carcinoma H1299(IC50=2.80±0.85µM),Human lung carcinoma H1975(IC50=2.00±0.65µM),Human lung carcinoma H1650(IC50=>5µM),Human lung carcinoma NCI-H460(IC50=>5µM),Human prostate cancer DU145(IC50=1.26±0.4µM),Human breast adenocarcinoma MDA-MB-231(IC50=4.70±1.2µM),Human breast adenocarcinoma MDA-MB-361(IC50=1.25±0.3µM),Human breast adenocarcinoma MCF-7(IC50=8.00±2.7µM),Human colon adenocarcinoma Colo205(IC50=0.75±0.2µM),Human colon adenocarcinoma HT29(IC50=3.70±0.8µM),Human colon adenocarcinoma Colo205(IC50=6.10±2.1µM),Human colon adenocarcinoma HCT 116(IC50=7.20±2.2µM),Human epidermoid cancer Hep2(IC50=4.30±1.2µM),Human liver carcinoma SK-HEP-1(IC50=6.00±1.9µM),Human breast adenocarcinoma MDA-MB-435(IC50=4.40±0.9µM),Human ovarian adenocarcinoma IGROV1(IC50=4.20±0.8µM),Human epithelial carcinoma OVCAR-3(IC50=7.30±2.2µM),Human pancreatic adenocarcinoma CAPAN-1(IC50=5.00±1.6µM),Human pancreatic carcinoma Mia PaCa-2(IC50=8.80±3.1µM),Human prostate adenocarcinoma PC-3(IC50=1.80±0.4µM)"
        }
    }
}